Trial Profile
A randomized, single blind trial evaluating efficacy of intranasal Fluticasone propionate/Azelastine hydrochloride in children with Allergic Rhinitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Mar 2018
Price :
$35
*
At a glance
- Drugs Azelastine/fluticasone-propionate (Primary) ; Azelastine; Fluticasone furoate
- Indications Allergic rhinitis
- Focus Therapeutic Use
- 23 Mar 2018 New trial record
- 05 Mar 2018 Results presented at the 2018 Annual Meeting of the American Academy of Allergy, Asthma and Immunology